Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
06.02.24
/
50%
€383.95
Target price
06.02.25
€502.09
Performance (%)
21.15%
End price
07.02.25
€465.15
Summary
This prediction ended on 07.02.25 with a price of €465.15. The BUY prediction by Wells_Fargo___Compan finished with a performance of 21.15%. Wells_Fargo___Compan has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -3.681% | -3.681% | 1.692% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Wells Fargo & Company from $500.00 to $540.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
28.44%
19:53
19:53
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
9.84%
19:53
19:53
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.50
10.01.25
10.01.25
€447.72
10.01.26
10.01.26
-0.30%
11.01.26
11.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25